OrganOx is at the forefront of changing the way donor livers are preserved in the critical time between donation and transplantation

OrganOx was founded in 2008 as a spin-out from the University of Oxford to advance the normothermic perfusion technology invented by Professor Peter Friend and colleagues, and further developed by Professor Constantin Coussios.

Our first product the metra®, received CE mark approval in 2016 and FDA-approval in 2021. Since then, the metra has supported over 1,500 transplants around the world, transforming the way donor livers are preserved and assessed, and helping to ensure more livers are available for transplantation.

Current opportunities to join our team

Located in our offices at the Oxford Science Park, Oxford UK, and in field-based positions throughout the world, OrganOx seeks to recruit and retain the best people from a broad range of backgrounds.

See opportunities


UK/US MD-040-4-1 - September 2022